Navigation Links
Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income
Date:9/24/2009

of 5.4 to 1 and $12.4 million in cash and cash equivalents on June 30, 2009. Stockholders' equity was $40.9 million, with working capital of $19.3 million$ and total liabilities of $4.4 million. Days Sales Outstanding for fiscal 2009 were 48 days compared to 49 days for 2008. For the fiscal year of 2009, the Company generated $8.3 million in cash from operations versus $3.7 million for the same period in 2008.

    Significant Business Developments
    -- Tianyin engaged a major advertising firm to commence a marketing
       initiative for its Xuelian Chongcao Oral Liquid product that will
       include prominent, prime-time advertisements on China Central
       Television (CCTV), China's most famous television station, which is
       viewed by 98% of households throughout China.  Xuelian Chongcao Oral
       Liquid is an Over-The-Counter TCM drug that effectively replenishes
       kidney functionality and also improves overall energy.
    -- Tianyin completed construction of its new production facility in
       Chengdu which recently received Good Manufacturing Practices
       Certificate for pharmaceutical products from the State Food and Drug
       Administration ("SFDA") in China.  Construction was delayed due to the
       earthquake in Sichuan which occurred on May 12, 2008.  The new
       production facility is expected to triple the production capacity of
       solid dosage drugs, such as Azithromycin Dispersible Tablets,
       Mycophenolate Mofetil Capsules, and Dantong Capsules, and will be able
       to support approximately $100 million in annual revenues assuming the
       current product mix.  The Company expects to commence production by
       October, 2009.
    -- Tianyin further expanded its product portfolio during fiscal 2009 which
       now totals 39 drugs.  The Company received 10 new production approvals
       from the Chinese SFDA for drugs which address multiple medical
       conditio
'/>"/>
SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
2. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
3. Tianyin Pharmaceutical Appoints Three New Independent Board Members
4. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
5. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
6. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
7. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
8. Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
9. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
10. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
11. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a project managed ... legal requirements around using controlled substances in pharmaceutical research, ... their international operations expand and become increasingly complex, large ... a result of the first phase of the CSCS ...
(Date:1/22/2015)...  Varian Medical Systems (NYSE: VAR ), world leader ... commitment to sustainability with inclusion on a prestigious list of ... healthcare equipment company among the Corporate Knights Global 100 Most ... at Davos, Switzerland . ...
(Date:12/24/2014)... DALLAS and NEW YORK , ... a biopharmaceutical company advancing patient care in critical areas, announced ... of common stock, and warrants to purchase up to an ... of $4.00 per share and $.01 per warrant.  The warrants ...
(Date:12/24/2014)... Earlier this year in a June 24 ... Adult Stem Cell Technology Center, LLC ( ASCTC ) focused ... of adult tissue stem cells. His title “Asymmetric Self-Renewal ... the Future,” embodied the essence of his message to congress ...
Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2Varian Honored Among World's 100 Most Sustainable Corporations 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... PRINCETON, N.J., Sept. 29 Covance Inc. (NYSE:,CVD) ... a 50-50 joint venture,with WuXi Pharmatech to provide ... China will become an attractive region for outsourced ... opportunity, we,will pursue our original strategy to build ...
... Inc.,("CTI" or the "Company") (Nasdaq: CTICD and ... purchase, for $14.2 million, newly,issued 15.5% Convertible Senior Notes ... The transaction is the result of an amendment of ... 2008) under which,the investor had purchased $9 million of ...
... Lu, former EVP of,Yahoo!, continues to dedicate his passion to ... USA. HYSTA is greatly,honored to have Qi,s on-going commitment as ... he had served more than 10,years, which was a big ... has not changed is his dedication to serve the Chinese,community ...
Cached Biology Technology:Covance Decides to Pursue Its Original Preclinical Strategy in China 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes 3Update: HYSTA Announces Dr. Qi Lu to Continue on as President of HYSTA, USA 2
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" report ... Facial recognition is a technology used ... the overall facial feature of a person such as ...
(Date:12/11/2014)... 2014  That blood pressure plays a role in human health ... medical term for high blood pressure – was first described ... cuff that,s used in measuring blood pressure was invented in ... about hypertension, its triggers and its effects. In fact, recent ...
(Date:12/10/2014)...  Valencell, a leader in performance biometric data sensor technology, ... its licensees for highly accurate, clinically validated biometric technology. ... from fitness and health sectors, but first responders/military and ... only as useful as the biometric data it delivers. ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... that global climate processes are affecting southern right whales ... by an international team of scientists found a strong ... Atlantic and El Nino in the western Pacific. The ... Biology Letters. , Southern right whales migrate from the ...
... may improve construction or repair of bones in the face, ... American Dental Association Foundation (ADAF) and the National Institute of ... upcoming journal articles,* the new technology provides a method for ... a patient's own cells and is formed with a cement ...
... when a mouse repeatedly experiences defeat by a dominant ... memory molecule in a brain circuit for social learning, ... National Institute of Mental Health (NIMH) have discovered. ... welcome strangers in spite of repeated social defeat. Their ...
Cached Biology News:Bioactive cement scaffold may improve bone grafts 2Mice lacking social memory molecule take bullying in stride 2Mice lacking social memory molecule take bullying in stride 3
... for Optimal Microdissection , CapSure HS and ... and rapid extraction of populations of pure ... with Laser Capture Microdissection., Ensure the ... Analysis , All CapSure LCM Caps have ...
... sensitive laser confocal systems designed for rapid ... that meet your expectations, differentiating between a ... the signal on the bottom as well ... for increased sensitivity. Results with VersArray ChipReader ...
... assays on four slides. The new ArraySlide ... 96 (6mm x 7mm) individual printing surfaces ... screening analysis studies. Unlike other systems, this ... the presence of contaminating adhesives. The chamber ...
... Use : GeneTraffic is built to be ... research. GeneTraffic provides visual and computational tools ... prior to analysis. , Data and ... using the MIAME (Minimum Information About a ...
Biology Products: